The End­points Slack in­ter­view: Lux's Josh Wolfe on AI hype, biotech mar­kets, Twit­ter and more

We’re try­ing some­thing new! Wel­come to the first End­points Slack In­ter­view, where we chat with in­ter­est­ing peo­ple in biotech, phar­ma, ven­ture cap­i­tal and sci­ence about what they’re work­ing on, what they think and who they are.

Our first con­ver­sa­tion is with Josh Wolfe, co­founder and man­ag­ing part­ner of Lux Cap­i­tal. He logged in to our top se­cret Slack chan­nel last week, and the con­ver­sa­tion has been very min­i­mal­ly edit­ed for read­abil­i­ty.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER